Invention Grant
- Patent Title: Solid forms of a transthyretin dissociation inhibitor
- Patent Title (中): 转甲状腺素解离抑制剂的固体形式
-
Application No.: US14345111Application Date: 2012-09-12
-
Publication No.: US09249112B2Publication Date: 2016-02-02
- Inventor: Richard Frederic Labaudiniere , Michael Henry O'Neill
- Applicant: Richard Frederic Labaudiniere , Michael Henry O'Neill
- Applicant Address: US NY New York
- Assignee: PFIZER INC.
- Current Assignee: PFIZER INC.
- Current Assignee Address: US NY New York
- International Application: PCT/IB2012/054748 WO 20120912
- International Announcement: WO2013/038351 WO 20130321
- Main IPC: C07D498/00
- IPC: C07D498/00 ; C07D263/57 ; C07H5/06
Abstract:
The present invention relates to solid forms of the N-methyl-D-glucamine (meglumine) salt of 6-carboxy-2-(3,5-dichlorophenyl)-benzoxazole and to methods for their preparation. The invention is also directed to pharmaceutical compositions containing at least one solid form and to the therapeutic or prophylactic use of such solid forms and compositions.
Public/Granted literature
- US20150031735A1 SOLID FORMS OF A TRANSTHYRETIN DISSOCIATION INHIBITOR Public/Granted day:2015-01-29
Information query
